Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing of a Memorandum of Understanding (MOU) with Hallym University Sacred Heart Hospital in Seoul, South Korea. This strategic alliance aims to drive innovation in drug research and development while strengthening collaboration across the medical and research sectors.
The collaboration outlines shared objectives focused on fostering innovation in health and health technology, accelerating drug research and development, and enhancing the efficiency of clinical trials, all while upholding the highest standards of quality and care. By uniting efforts, HiRO and Hallym University Sacred Heart Hospital are well-positioned to make significant progress in improving healthcare outcomes and addressing unmet clinical needs for patients in South Korea and beyond.
Hallym University Sacred Heart Hospital, equipped with cutting-edge facilities and a highly skilled team of medical professionals, specializes in various therapeutic areas and is fully capable of conducting clinical trials ranging from early to late stages in accordance with ICH-GCP guidelines. In turn, HiRO will leverage its extensive global experience and strong presence in the US, Europe, and Asia-Pacific regions to optimize clinical research efficiency, and proactively introduce multiregional trials to South Korea and the hospital.
Dr. Karen Chu, Founder and CEO of HiRO, remarked, “Hallym University Sacred Heart Hospital’s robust clinical trial capabilities, combined with HiRO’s extensive experience and our global leadership team’s expertise, averaging 20 years in the field, will streamline workflows and accelerate timelines, ensuring the effective delivery of pioneering treatments to the market. This partnership not only seeks to drive innovation but also to cultivate international collaborations that will lead to meaningful advancements in medical research on a global scale.
Prof. Hyung-soo Kim, Director of Hallym University Sacred Heart Hospital added, “This agreement symbolizes a remarkable opportunity to provide patients with more innovative treatment options. By integrating our clinical research capabilities with HiRO’s global network, we aim to create a transformative collaboration model that bridges medical practice, research, and industry.”
Through this agreement, both HiRO and Hallym University Sacred Heart Hospital are set to establish a partnership that strives for mutual success in clinical research and delivering more effective treatments, consequently enhancing health outcomes for patients both locally and globally.
About Harvest Integrated Research Organization (HiRO)
Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO). With global operations and integrated capabilities, HiRO provides a full range of cross-border solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design, regulatory affairs, pharmacovigilance, statistics, data management, end-to-end project management, and clinical and medical monitoring services.
As an emerging global CRO, HiRO strives to become a market-leading, integrated global clinical research organization that works collaboratively with biotech and pharmaceutical companies to bring new products from the laboratory to the market, providing more effective solutions for patients worldwide. For more information, please visit www.harvestiro.com.
About Hallym University Sacred Heart Hospital
Hallym University Sacred Heart Hospital, founded in January 1999, is a renowned tertiary hospital located in Seoul, Korea, dedicated to delivering outstanding healthcare services. The hospital is celebrated for its exceptional faculty and state-of-the-art medical technology, creating a patient-centered environment that prioritizes the health and satisfaction of every individual it serves.
Specializing in multidisciplinary, integrated care, Hallym University Sacred Heart Hospital excels in treating severe and acute conditions while driving medical innovation through the Doheon Digital Medical Innovation Research Institute. This institute focuses on advancements in AI, Big Data, and robotics to enhance healthcare delivery and improve patient outcomes. For more information, please visit https://eng.hallym.or.kr/.
This press release was first published at PR Newswire.
